[New principles of treatment in acute leukemia].
D000293:Adolescent; D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002493:Central Nervous System Diseases / Q000188:drug therapy; D002648:Child; D003520:Cyclophosphamide / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D005260:Female; D006146:Guanidines / Q000627:therapeutic use; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy*; D007970:Leukopenia / Q000188:drug therapy; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D009603:Nitroso Compounds / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D013921:Thrombocytopenia / Q000188:drug therapy; D014508:Urea / Q000627:therapeutic use; D014527:Uric Acid / Q000097:blood; D014750:Vincristine / Q000627:therapeutic use
D000970:Antineoplastic Agents; D006146:Guanidines; D009603:Nitroso Compounds; D003561:Cytarabine; D014527:Uric Acid; D014750:Vincristine; D003520:Cyclophosphamide; D014508:Urea; D015122:Mercaptopurine; D011241:Prednisone; D006918:Hydroxyurea; D008727:Methotrexate
Nye behandlingsprincipper ved akut leukaemi.